Home About Us Government Relations and Advocacy Media Contact Us Site Map Privacy Français  
Multiple Sclerosis Society of CanadaSociété canadienne de la sclérose en plaquesfinding a cure - enhancing quality of life
Multiple Sclerosis Living with Multiple Sclerosis Treatments Donate Now Get Involved Special Events

 

News in Research

Research We Fund

Research Explained

Take Part in Research

Apply for a Research Grant

Search Research

Donate Now to Research


Research Home

Helpful links:

Stem Cell Research

MS Scientific Research Foundation

Research Summaries

MS Research Accomplishments



Research
  Small FontMedium FontLarge Font

Study Examines Exposure to Sunlight and Risk of Developing Multiple Sclerosis

Medical Update Memo
August 20, 2003

Research conducted in Australia's most southerly state of Tasmania suggests that higher exposure to ultraviolet light delivered through sunshine may reduce the risk of developing MS. The benefit appears to be linked to increased sun exposure in children and young adolescents. The result of the study, which involved 136 people with MS and 272 non-MS controls living in Tasmania, was published in the August 9, 2003 issue of the British Medical Journal.

Background

  • Multiple sclerosis has a well-known and varied distribution throughout the world. It is more common in countries that are farther away from the equator. It also has a striking north-south gradient, i.e., MS is more common in the northern United States than in the south, and conversely, is more common in southern Australia than in the north.
  • A number of environmental and genetic factors have been investigated to try to understand this variation including migration patterns and exposure to common viruses. More recently, researchers have turned their attention to the possible role of sunlight in preventing the development of MS.
  • Researchers at the University of Tasmania studied sunlight exposure of 136 people with MS compared to that of 272 non-MS matched controls. They used questionnaires to ascertain the amount of time individuals had spent in the sun during the early part of their lives. Tests for sun damage to the skin were conducted to provide objective backup for possible faulty memories.
  • The researchers found that people who had spent more time in the sun when they were between the ages of six and 15 were less likely to develop MS than those who had less exposure to sunlight. Having higher sun exposure during the winter months seemed particularly important.
  • Sunlight delivers ultraviolet radiation, which upon coming in contact with the skin, stimulates the body to produce Vitamin D. Several studies have shown that ultraviolet radiation and Vitamin D suppress the activity of immune T cells. Several other studies involving an animal model of MS found the animal disease could be prevented or delayed by giving ultraviolet radiation or the active form of Vitamin D. MS appears to be the result of certain T cells mistakenly attacking the body's own tissues, including myelin, the vital protective cover of the central nervous system.
  • While the study of sunlight exposure and MS risk in Tasmania is promising, larger studies must be conducted to determine if higher levels of sunlight or Vitamin D supplements can actually prevent the development of MS, cautioned Dr. William J. McIlroy, national medical advisor.
  • It should also be noted that unprotected exposure to sunlight is linked to the development of skin cancer and premature skin aging. Not enough is known about Vitamin D supplementation in people to determine if it or heightened exposure to sunlight during childhood and early adolescence can prevent multiple sclerosis.


ASK MS Information System Code 1.4.3.8.1.g

National Research Department
National Communications & Social Action Department

Click here to view or print this bulletin in its original format.

Get Acrobat   You will need ADOBE ACROBAT READER to view this document listed above - it's FREE.

Disclaimer
The Multiple Sclerosis Society of Canada is an independent, voluntary health agency and does not approve, endorse or recommend any specific product or therapy but provides information to assist individuals in making their own decisions.

line
 
Multiple Sclerosis Society of Canada
Toll free to reach the nearest regional office: 1 800 268-7582

To locate the MS Society office near you, please select your region:

E-mail: info@mssociety.ca
(Please provide your town and province in your e-mail)

Multiple Sclerosis   Living with MS   Research   Treatments   Donate Now   Get Involved    Special Events

Home    About Us    Advocacy    Media    Contact Us    Site Map    Privacy    Français